{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:33:23Z","timestamp":1794047603635,"version":"4.8.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"World Association of Infectious Diseases and Immunological Disorders (WAidid)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vaccine.2018.08.036","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T09:23:51Z","timestamp":1534757031000},"page":"5825-5831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Aluminum in vaccines: Does it create a safety problem?"],"prefix":"10.1016","volume":"36","author":[{"given":"Nicola","family":"Principi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.08.036_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0264-410X(02)00163-9","article-title":"Workshop summary Aluminum in vaccines","volume":"20","author":"Eickhoff","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.036_b0010","unstructured":"World Health Organization. Global Advisory Committee on Vaccine Safety, June 2012. Weekly Epidemiol Rec 2012; 30:281\u2013288 U.S. Food and Drug Administration. Study reports aluminum in vaccines poses extremely low risk to infants. Available at: <https:\/\/www.fda.gov\/biologicsbloodvaccines\/scienceresearch\/ucm284520.htm> [accessed on: November 7, 2017]."},{"key":"10.1016\/j.vaccine.2018.08.036_b0015","unstructured":"Centers for Disease Control and Prevention. Vaccine adjuvants. Available at: <https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/adjuvants.html> [accessed on November 7, 2017]."},{"key":"10.1016\/j.vaccine.2018.08.036_b0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/14740338.2016.1167869","article-title":"Adverse events following immunization: real causality and myths","volume":"15","author":"Principi","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2018.08.036_b0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.morpho.2016.01.002","article-title":"Aluminum adjuvants of vaccines injected into the muscle: normal fate, pathology and associated disease","volume":"100","author":"Gherardi","year":"2016","journal-title":"Morphologie"},{"key":"10.1016\/j.vaccine.2018.08.036_b0030","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11011-017-0077-2","article-title":"The putative role of environmental aluminum in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved?","volume":"32","author":"Morris","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.vaccine.2018.08.036_b0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.morpho.2015.12.003","article-title":"The toxicity of aluminum in humans","volume":"100","author":"Exley","year":"2016","journal-title":"Morphologie"},{"key":"10.1016\/j.vaccine.2018.08.036_b0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fneur.2015.00004","article-title":"Biopersistence and brain translocation of aluminum adjuvants of vaccines","volume":"6","author":"Gherardi","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12026-013-8403-1","article-title":"Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity","volume":"56","author":"Shaw","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2018.08.036_b0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/imt.14.81","article-title":"Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?","volume":"6","author":"Shaw","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.vaccine.2018.08.036_b0055","series-title":"Aluminum. Miller\u2019s review of critical vaccine studies. 400 important scientific papers summarized for parents and researchers","first-page":"44","author":"Miller","year":"2016"},{"key":"10.1016\/j.vaccine.2018.08.036_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jinorgbio.2017.08.035","article-title":"Subcutaneous injections of aluminum at vaccine adjuvant levels activate innate immune genes in mouse brain that are homologous with biomarkers of autism","volume":"177","author":"Li","year":"2017","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.vaccine.2018.08.036_b0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4065\/mcp.2011.0467","article-title":"MMR vaccine and autism: vaccine nihilism and postmodern science","volume":"86","author":"Poland","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.08.036_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10937400701597766","article-title":"Human health risk assessment for aluminum, aluminum oxide, and aluminum hydroxide","volume":"10","author":"Krewski","year":"2007","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.vaccine.2018.08.036_b0075","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM198505233122101","article-title":"Evidence of aluminum loading in infants receiving intravenous therapy","volume":"312","author":"Sedman","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.036_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1039\/B314329P","article-title":"The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update","volume":"6","author":"Priest","year":"2004","journal-title":"J Environ Monit"},{"key":"10.1016\/j.vaccine.2018.08.036_b0085","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1016\/j.vaccine.2011.09.124","article-title":"Updated aluminum pharmacokinetics following infant exposures through diet and vaccination","volume":"29","author":"Mitkus","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.08.036_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2014.934439","article-title":"Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts","volume":"44","author":"Willhite","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0095","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)93016-3","article-title":"Aluminum absorption studied by 26Al tracer","volume":"337","author":"Day","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.036_b0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0278-6915(83)90105-9","article-title":"Excretion and retention of low or moderate levels of aluminum by human subjects","volume":"21","author":"Greger","year":"1983","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0148607188012002170","article-title":"Aluminum contamination of infant formulas","volume":"12","author":"Koo","year":"1988","journal-title":"J Parenteral Nutr"},{"key":"10.1016\/j.vaccine.2018.08.036_b0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/adc.61.9.914","article-title":"High aluminum content of infant milk formulas","volume":"61","author":"Weintraub","year":"1986","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2018.08.036_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1754.1990.tb02370.x","article-title":"Aluminum concentrations in infant formulae","volume":"26","author":"Simmer","year":"1990","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2018.08.036_b0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005176-199411000-00002","article-title":"Potential aluminum toxicity in infants fed special infant formula","volume":"19","author":"Hawkins","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2018.08.036_b0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0048-9697(95)04702-4","article-title":"Aluminum levels in human milk","volume":"170","author":"Mandic","year":"1995","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.vaccine.2018.08.036_b0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/02652039509374286","article-title":"Estimates of dietary exposure to aluminum","volume":"12","author":"Pennington","year":"1995","journal-title":"Food Addit Contam"},{"key":"10.1016\/j.vaccine.2018.08.036_b0135","unstructured":"U.S. Department of Health and Human Services. Toxicological profile for aluminum. Available at: <https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp22.pdf> [accessed on: November 9, 2017]."},{"key":"10.1016\/j.vaccine.2018.08.036_b0140","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2015.10.076","article-title":"Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children","volume":"33","author":"Glanz","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2018.08.036_b0145","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0264-410X(02)00165-2","article-title":"Aluminum toxicokinetics regarding infant diet and vaccinations","volume":"20","author":"Keith","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.036_b0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pharma.2017.04.004","article-title":"Critical analysis of reference studies on aluminum-based adjuvants toxicokinetics","volume":"75","author":"Masson","year":"2017","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.vaccine.2018.08.036_b0155","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.036_b0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1741-7015-11-99","article-title":"Slow CCL2-dependent translocation of biopersistent particles from muscle to brain","volume":"11","author":"Khan","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2018.08.036_b0165","article-title":"Link between aluminum and the pathogenesis of Alzheimer's Disease: the integration of the aluminum and amyloid cascade hypotheses","volume":"2011","author":"Kawahara","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.vaccine.2018.08.036_b0170","unstructured":"Agency for Toxic Substances and Disease Registry. Minimal Risk Levels (MRLs) for Hazardous Substances. Aluminum. Available at: <https:\/\/www.atsdr.cdc.gov\/mrls\/mrllist.asp#34tag> [accessed on: November 9, 2017]."},{"key":"10.1016\/j.vaccine.2018.08.036_b0175","unstructured":"World Health Organization. Joint FAO\/WHO Expert Committee on Food Additives: Safety evaluation of certain food additives and contaminants. Available on: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/44788\/1\/WHO_TRS_966_eng.pdf>; 2012 [accessed on: November 9, 2017]."},{"key":"10.1016\/j.vaccine.2018.08.036_b0180","first-page":"1","article-title":"Safety of aluminum from dietary intake, scientific opinion of the panel on food additives, flavourings, processing aids and food contact materials (AFC)","author":"European Food Safety Authority","year":"2008","journal-title":"EFSA J"},{"key":"10.1016\/j.vaccine.2018.08.036_b0185","doi-asserted-by":"crossref","unstructured":"Deutsche Forschungsgemeinschaft: MAK- und BAT-Werte-Liste 2017: Maximale Arbeitsplatzkonzentrationen und Biologische Arbeitsstofftoleranzwerte. St\u00e4ndige Senatskommission zur Pr\u00fcfung gesundheitssch\u00e4dlicher Arbeitsstoffe. Mitteilung 53. Weinheim: Wiley-VCH; 2017.","DOI":"10.1002\/9783527812110"},{"key":"10.1016\/j.vaccine.2018.08.036_b0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00420-007-0191-2","article-title":"Longitudinal study on potential neurotoxic effects of aluminum: I. Assessment of exposure and neurobehavioral performance of Al welders in the train and truck construction industry over 4 years","volume":"81","author":"Kiesswetter","year":"2007","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.vaccine.2018.08.036_b0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.etap.2004.12.036","article-title":"Neurotoxicity of exposures to aluminum welding fumes in the truck trailer construction industry","volume":"19","author":"Buchta","year":"2005","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/jcp.34.11.1285","article-title":"Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis","volume":"34","author":"Parkinson","year":"1981","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0205","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1542\/peds.2010-3481","article-title":"Wide variation in reference values for aluminum levels in children","volume":"129","author":"Zeager","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.08.036_b0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5271\/sjweh.521","article-title":"Body burden of aluminum in relation to central nervous system function among metal inert-gas welders","volume":"26","author":"Riihim\u00e4ki","year":"2000","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.vaccine.2018.08.036_b0215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/00207450390232292","article-title":"A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum","volume":"113","author":"Miu","year":"2003","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.vaccine.2018.08.036_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00420-007-0191-2","article-title":"Longitudinal study on potential neurotoxic effects of aluminum: I. Assessment of exposure and neurobehavioral performance of Al welders in the train and truck construction industry over 4 years","volume":"81","author":"Kiesswetter","year":"2007","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.vaccine.2018.08.036_b0225","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00420-009-0414-9","article-title":"Longitudinal study on potential neurotoxic effects of aluminum: II. Assessment of exposure and neurobehavioral performance of Al welders in the automobile industry over 4 years","volume":"82","author":"Kiesswetter","year":"2009","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.vaccine.2018.08.036_b0230","first-page":"123","article-title":"Aluminum intoxication in renal disease","volume":"169","author":"Kerr","year":"1992","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.vaccine.2018.08.036_b0235","first-page":"653","article-title":"The health effects of aluminum exposure","volume":"114","author":"Klotz","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.vaccine.2018.08.036_b0240","first-page":"689","article-title":"Elevated serum aluminum levels in hemodialysis patients associated with use of electric pumps\u2013Wyoming, 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.08.036_b0245","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.ajkd.2011.08.008","article-title":"Hyperaluminemia during long-term dialysis: still relevant today","volume":"58","author":"Christie","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.vaccine.2018.08.036_b0250","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3747\/pdi.2011.00203","article-title":"Risk factors and consequences of hyperaluminemia in a peritoneal dialysis cohort","volume":"32","author":"Lavergne","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.vaccine.2018.08.036_b0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0029665111000498","article-title":"Aluminum exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence","volume":"70","author":"Fewtrell","year":"2011","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.vaccine.2018.08.036_b0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/iep.12122","article-title":"The protective properties of melatonin against aluminum-induced neuronal injury","volume":"96","author":"Al-Olayan","year":"2015","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0265","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1017\/S0317167100029838","article-title":"A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry","volume":"16","author":"Jacobs","year":"1989","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.vaccine.2018.08.036_b0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(91)90158-P","article-title":"Absence of aluminum in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies","volume":"123","author":"Chafi","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.vaccine.2018.08.036_b0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/360065a0","article-title":"Absence of aluminum in neuritic plaque cores in Alzheimer's disease","volume":"360","author":"Landsberg","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.08.036_b0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ana.410330107","article-title":"Laser microprobe analysis of brain aluminum in Alzheimer's disease","volume":"33","author":"Lovell","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0285","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/aje\/kwn348","article-title":"Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort","volume":"169","author":"Rondeau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0290","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JOM.0000000000000487","article-title":"Occupational exposure to aluminum and Alzheimer disease: a meta-analysis","volume":"57","author":"Virk","year":"2015","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.vaccine.2018.08.036_b0295","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1192\/bjp.168.2.244","article-title":"A case-control study of Alzheimer\u2019s disease and aluminum occupation","volume":"168","author":"Salib","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.vaccine.2018.08.036_b0300","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2015.11.014","article-title":"Chronic exposure to aluminum and risk of Alzheimer's disease: a meta-analysis","volume":"610","author":"Wang","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.vaccine.2018.08.036_b0305","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JAD-132204","article-title":"Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria","volume":"40","author":"Walton","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.vaccine.2018.08.036_b0310","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinorgbio.2013.07.022","article-title":"Tomljenovic L Administration of aluminum to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes","volume":"128","author":"Shaw","year":"2013","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.vaccine.2018.08.036_b0315","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jinorgbio.2011.08.008","article-title":"Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?","volume":"105","author":"Tomljenovic","year":"2011","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.vaccine.2018.08.036_b0320","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.2174\/092986711795933740","article-title":"Aluminum vaccine adjuvants: are they safe?","volume":"18","author":"Tomljenovic","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.vaccine.2018.08.036_b0325","article-title":"Blood and hair aluminum levels, vaccine history, and early infant development: a cross-sectional study","author":"Karwowski","year":"2017","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2018.08.036_b0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019\u2014autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2018.08.036_b0335","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203316686406","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome)\u2014an update","volume":"26","author":"Watad","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2018.08.036_b0340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.03.003","article-title":"Sjogren\u2019s syndrome: another facet of the autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)","volume":"51","author":"Colafrancesco","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2018.08.036_b0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.phrs.2014.10.005","article-title":"Is narcolepsy a classical autoimmune disease?","volume":"92","author":"Arango","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.vaccine.2018.08.036_b0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12026-014-8622-0","article-title":"Adjuvants and lymphoma risk as part of the ASIA spectrum","volume":"61","author":"Butnaru","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2018.08.036_b0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12026-016-8811-0","article-title":"Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome)","volume":"65","author":"Jara","year":"2017","journal-title":"Immunol Res"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2018.08.036_b0360","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12026-014-8586-0","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background","volume":"60","author":"Esposito","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2018.08.036_b0365","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jaip.2017.06.033","article-title":"Evidence Refuting the existence of autoimmune\/autoinflammatory syndrome induced by adjuvants (ASIA)","volume":"5","author":"Ameratunga","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.vaccine.2018.08.036_b0370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaci.2011.09.007","article-title":"Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality","volume":"129","author":"Linneberg","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0375","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.036_b0380","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/0961203307078225","article-title":"Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus","volume":"16","author":"Kuruma","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2018.08.036_b0385","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnen\/62.5.464","article-title":"Inflammatory myopathy with abundant macrophages (IMAM): a condition distinct from macrophagic myofasciitis, sharing similarities with cytophagic histiocytic panniculitis","volume":"62","author":"Bassez","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0390","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00296-014-3065-4","article-title":"Macrophagic myofasciitis and vaccination: consequence or coincidence?","volume":"35","author":"Santiago","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2018.08.036_b0395","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.10740","article-title":"Chronic fatigue syndrome in patients with macrophagic myofasciitis","volume":"48","author":"Authier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2018.08.036_b0400","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0883073807312370","article-title":"Macrophagic myofasciitis in children is a localized reaction to vaccination","volume":"23","author":"Lach","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0405","first-page":"172","article-title":"Pediatric macrophagic myofasciitis associated with motor delay","volume":"25","author":"Gruis","year":"2006","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10024001-0137-8","article-title":"Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis","volume":"5","author":"Lacson","year":"2002","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0415","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nmd.2003.12.005","article-title":"Childhood macrophagic myofasciitis\u2014consanguinity and clinicopathological features","volume":"14","author":"Nevo","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.vaccine.2018.08.036_b0420","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0035-1557224","article-title":"Macrophagic myofasciitis in a 3-month-old child","volume":"2","author":"Sharma","year":"2004","journal-title":"J Pediatr Neurol"},{"key":"10.1016\/j.vaccine.2018.08.036_b0425","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","article-title":"Aluminum assay and evaluation of the local reaction at several time points after intramuscular administration of aluminum containing vaccines in the Cynomolgus monkey","volume":"23","author":"Verdier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.036_b0430","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/art.10465","article-title":"HLADRB1*01 and macrophagic myofasciitis","volume":"46","author":"Guis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2018.08.036_b0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2018.08.036_b0440","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/09298673113206660287","article-title":"Selective elevation of circulating CCL2\/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA","volume":"21","author":"Cadusseau","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.vaccine.2018.08.036_b0445","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/0300974051007913","article-title":"Macrophagic myofasciitis unrelated to vaccination","volume":"34","author":"Park","year":"2005","journal-title":"Scand J Rheumatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T12:20:26Z","timestamp":1571746826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":89,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0264410X18311654"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aluminum in vaccines: Does it create a safety problem?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}